You just read:

Asterias Biotherapeutics Announces Interim Efficacy Data from SCiStar Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury Patients to be Presented at the 55th ISCoS Annual Scientific Meeting

News provided by

Asterias Biotherapeutics, Inc.

Sep 07, 2016, 07:00 ET